Search research articles
Contact Us
Filters
Showing results (101-110 of 143) with videos related to
Page
of 15
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
Jacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
The Journal of Pathology
|
November 23, 2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
Michele Simbolo, Andrea Mafficini, Katarzyna O Sikora, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 10, 2023
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
Antonio Nuccio, Giuseppe Viscardi, Fabio Salomone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C Arbour, Laura Mezquita, Niamh Long, et al.
Frontiers in Immunology
|
October 7, 2022
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC
Diego Signorelli, Patrizia Ghidotti, Claudia Proto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
Arsela Prelaj, Achille Bottiglieri, Claudia Proto, et al.
Cancer Treatment Reviews
|
November 2, 2023
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Francesco Maria Venanzi, Marta Bini, Antonio Nuccio, et al.
JAMA Oncology
|
January 13, 2018
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita, Edouard Auclin, Roberto Ferrara, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
World Journal of Emergency Surgery : WJES
|
November 6, 2012
Italian Biological Prosthesis Work-Group (IBPWG): proposal for a decisional model in using biological prosthesis
Federico Coccolini, Ferdinando Agresta, Andrea Bassi, et al.
Page
of 15
Search research articles
Search
Showing results (101-110 of 143) with videos related to
Sort By:
Page
of 15
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
March 10, 2024
Evaluation of Major Pathologic Response and Pathologic Complete Response as Surrogate End Points for Survival in Randomized Controlled Trials of Neoadjuvant Immune Checkpoint Blockade in Resectable in NSCLC
Jacobi B Hines, Robert B Cameron, Alessandra Esposito, et al.
The Journal of Pathology
|
November 23, 2016
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D
Michele Simbolo, Andrea Mafficini, Katarzyna O Sikora, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 10, 2023
Systematic review and meta-analysis of immune checkpoint inhibitors as single agent or in combination with chemotherapy in early-stage non-small cell lung cancer: Impact of clinicopathological factors and indirect comparison between treatment strategies
Antonio Nuccio, Giuseppe Viscardi, Fabio Salomone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 21, 2018
Impact of Baseline Steroids on Efficacy of Programmed Cell Death-1 and Programmed Death-Ligand 1 Blockade in Patients With Non-Small-Cell Lung Cancer
Kathryn C Arbour, Laura Mezquita, Niamh Long, et al.
Frontiers in Immunology
|
October 7, 2022
Circulating CD81-expressing extracellular vesicles as biomarkers of response for immune-checkpoint inhibitors in advanced NSCLC
Diego Signorelli, Patrizia Ghidotti, Claudia Proto, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 6, 2021
Poziotinib for EGFR and HER2 exon 20 insertion mutation in advanced NSCLC: Results from the expanded access program
Arsela Prelaj, Achille Bottiglieri, Claudia Proto, et al.
Cancer Treatment Reviews
|
November 2, 2023
Sex dimorphism and cancer immunotherapy: May pregnancy solve the puzzle?
Francesco Maria Venanzi, Marta Bini, Antonio Nuccio, et al.
JAMA Oncology
|
January 13, 2018
Association of the Lung Immune Prognostic Index With Immune Checkpoint Inhibitor Outcomes in Patients With Advanced Non-Small Cell Lung Cancer
Laura Mezquita, Edouard Auclin, Roberto Ferrara, et al.
Science Advances
|
November 8, 2023
Human virome profiling identified CMV as the major viral driver of a high accumulation of senescent CD8<sup>+</sup> T cells in patients with advanced NSCLC
Marie Naigeon, Matthieu Roulleaux Dugage, François-Xavier Danlos, et al.
World Journal of Emergency Surgery : WJES
|
November 6, 2012
Italian Biological Prosthesis Work-Group (IBPWG): proposal for a decisional model in using biological prosthesis
Federico Coccolini, Ferdinando Agresta, Andrea Bassi, et al.
Page
of 15